Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Teprotumumab (Tepezza) for Thyroid Eye Disease
Steven M. Couch
Department of Ophthalmology and Visual Sciences
Institute of Clinical and Translational Sciences (ICTS)
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Teprotumumab (Tepezza) for Thyroid Eye Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chemotherapy
25%
Clinical Aspects
25%
Diplopia
25%
Disease-modifying Therapy
25%
Facial Disfigurement
25%
Federal Drug Administration
25%
Immune Response
25%
Infiltration
25%
Inflammation
25%
Inflammatory Diseases
25%
Inflammatory Phase
25%
Medical Modalities
25%
Orbital Radiation
25%
Orbital Soft Tissue
50%
Proptosis
25%
Quality of Life
25%
Quiescent Infection
25%
Steroid-sparing
25%
Surgical Intervention
25%
Tepezza
100%
Teprotumumab
100%
Therapy Interventions
25%
Thyroid Eye Disease
100%
Medicine and Dentistry
Clinical Feature
25%
Diplopia
25%
Disease Modifying Therapy
25%
Diseases
25%
Drug Administration
25%
Endocrine Ophthalmopathy
100%
Exophthalmos
25%
Quality of Life
25%
Teprotumumab
100%
Immunology and Microbiology
Graves' Ophthalmopathy
100%
Soft Tissue
25%
Teprotumumab
100%